Adult Glioma WHO Classification Update, Genomics, and Imaging: What the Radiologists Need to Know

• Published in: Topics in magnetic resonance imaging Vol. 29; no. 2; pp. 71 - 82
• Main Authors: Bai, James, Varghese, Jerrin, Jain, Rajan
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health, Inc. All rights reserved 01.04.2020
• Subjects: Adult; Biomarkers, Tumor; Brain - diagnostic imaging; Brain Neoplasms - classification; Brain Neoplasms - diagnostic imaging; Brain Neoplasms - genetics; Genomics; Glioma - classification; Glioma - diagnostic imaging; Glioma - genetics; Humans; Magnetic Resonance Imaging - methods; Prognosis; Radiologists; World Health Organization
• ISSN: 0899-3459; 1536-1004; 1536-1004
• DOI: 10.1097/RMR.0000000000000234

Recent advances in the understanding of the genetic makeup of gliomas have led to a paradigm shift in the diagnosis and classification of these tumors. Driven by these changes, the World Health Organization (WHO) introduced an update to its classification system of central nervous system (CNS) tumors in 2016. The updated glioma classification system incorporates molecular markers into tumor subgrouping, which has been shown to better correlate with tumor biology and behavior as well as patient prognosis than the previous purely histology-based classification system. Familiarity with this new classification scheme, the individual molecular markers, and corresponding imaging findings is critical for the radiologists who play an important role in diagnostic and surveillance imaging of patients with CNS tumors. The goals of this article are to review these updates to the WHO classification of CNS tumors with a focus on adult gliomas, provide an overview of key genomic markers of gliomas, and review imaging features pertaining to various genomic subgroups of adult gliomas.